No Data
No Data
Natera Is Maintained at Buy by Canaccord Genuity
Natera Analyst Ratings
CCORF Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $180
Natera (NTRA) Q4 Earnings: What To Expect
CareDx: All Patent Claims Asserted Against Company Are Found to Be Invalid >CDNA
CareDx Announces District Court Reverses Jury Decision in Patent Infringement Case, Overturning Prior $96M Verdict